Insights

Strategic Acquisition KCR has become part of ICON plc through an August 2024 acquisition, creating a larger, integrated CRO platform. This presents opportunities to cross-sell ICON capabilities to KCR’s biotech clients and leverage KCR’s bespoke biotech-focused delivery with ICON’s global scale.

Biotech Focus KCR’s specialized services for emerging biotech companies suggest a strong potential to expand high-growth, early-stage biotech engagements. Sales should target expanding scope within this segment, offering integrated end-to-end CRO solutions that align with biotech R&D timelines.

Global Reach The combination leverages ICON’s global footprint to extend KCR’s client base and geographic coverage. Opportunity exists to win multinational programs that require consistent CRO delivery across regions, with streamlined project governance and standardized processes.

Digital & Tech Enablement KCR’s tech stack includes tools for recruitment, content, collaboration, and data management. This indicates potential for selling advanced digital CRO solutions, data integration, and scalable DevOps-like pipelines for trial execution and reporting.

Financial Scale With revenue in the multi-billion range for ICON and KCR’s mid-sized profile, there is potential to upsell larger, longer-term programs, optimize pricing and efficiency through ICON’s enterprise platforms, and pursue expanded services such as early-phase to late-stage programs across the combined entity.

Similar companies to KCR

KCR Tech Stack

KCR uses 8 technology products and services including LinkedIn Recruiter, Canva, WordPress, and more. Explore KCR's tech stack below.

KCR's Email Address Formats

KCR uses at least 8 email formats:
KCR Email FormatsExamplePercentage
First.Last@kcrcro.comJohn.Doe@kcrcro.com
93%
Last@kcrcro.comDoe@kcrcro.com
4%
FirstLast@kcrcro.comJohnDoe@kcrcro.com
2%
Last.First@kcrcro.comDoe.John@kcrcro.com
1%
First.Last@iconplc.comJohn.Doe@iconplc.com
93%
FirstLast@iconplc.comJohnDoe@iconplc.com
4%
First.L@iconplc.comJohn.D@iconplc.com
2%
Last.First@iconplc.comDoe.John@iconplc.com
1%

Frequently Asked Questions

What is KCR's phone number?

Minus sign iconPlus sign icon
You can contact KCR's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is KCR's stock symbol?

Minus sign iconPlus sign icon
KCR is a publicly traded company; the company's stock symbol is RCGE.

What is KCR's official website and social media links?

Minus sign iconPlus sign icon
KCR's official website is iconplc.com and has social profiles on LinkedIn.

How much revenue does KCR generate?

Minus sign iconPlus sign icon
As of October 2026, KCR's annual revenue is estimated to be $1B - $10B.

What is KCR's NAICS code?

Minus sign iconPlus sign icon
KCR's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does KCR have currently?

Minus sign iconPlus sign icon
As of October 2026, KCR has approximately 482 employees across 6 continents, including Europe, North America and Asia. Key team members include Chief Executive Officer: D. D., Chief Financial Officer: P. B. and Chief Technology Officer: D. B. Explore KCR's employee directory with LeadIQ.

What industry does KCR belong to?

Minus sign iconPlus sign icon
KCR operates in the Pharmaceutical Manufacturing industry.

What technology does KCR use?

Minus sign iconPlus sign icon
KCR's tech stack includes LinkedIn Recruiter, Canva, WordPress, GitLab CI, Adobe Experience Cloud, MongoDB, Articulate 360 and Coupa.

What is KCR's email format?

Minus sign iconPlus sign icon
KCR's email format typically follows the pattern of First.Last@kcrcro.com. Find more KCR email formats with LeadIQ.

When was KCR founded?

Minus sign iconPlus sign icon
KCR was founded in 1997.
KCR logo

KCR

Pharmaceutical ManufacturingMasovian, Poland201-500 Employees

KCR operates as a contract research organization within pharmaceutical development, providing tailored services to emerging biotechnology companies. In August 2024, ICON plc completed its acquisition of KCR, bringing the Polish CRO into ICON’s global organization. The integration gives access to greater resources to support growth and development. The combined entity emphasizes collaborative culture and accountability, aiming to deliver innovative clinical development solutions for sponsors by leveraging KCR’s client-focused delivery with ICON’s scale. Based in Warsaw, in the Masovian region of Poland, the company sits within ICON’s worldwide network as a mid-sized CRO serving early-stage biotech clients.

Section iconCompany Overview

Phone number
Stock Symbol
RCGE
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1997
Employees
201-500

Section iconFunding & Financials

  • $1B - $10B

    KCR's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.